SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-007490
Filing Date
2023-05-05
Accepted
2023-05-05 18:25:54
Documents
1
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 form3-05052023_100544.html 3  
1 form3-05052023_100544.xml 3 2746
  Complete submission text file 0001415889-23-007490.txt   4353
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3529 TILDEN STREET, NW WASHINGTON DC 20008
Business Address
Cote Timothy R. (Reporting) CIK: 0001799061 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14778 | Film No.: 23895385